The number of treatments for children with rare diseases has grown over the past decade, according to a new study. However,…
Articles by Patricia Inácio, PhD
Researchers have discovered that patients with pulmonary sarcoidosis have an imbalance in two subsets of immune cells, namely B-cells…
The lungs of patients with sarcoidosis are burdened with a more active subset of immune T-cells, called mucosal-associated…
The current scoring system used to assess the urgency of lung transplants, called LAS (lung allocation score), fails to…
While there no therapies approved for sarcoidosis-associated pulmonary hypertension (SAPH), pulmonary hypertension-specific therapies may help ease right heart dysfunction…
The investigational therapy ATYR1923 for pulmonary sarcoidosis may help decrease lung inflammation by halting the infiltration of immune…
A literature review of research performed in specific populations from countries worldwide estimated a heritability of 60 to 70 percent…
Middle-aged adults with impaired lung function, such as people with sarcoidosis, are at higher risk of dementia and mild cognitive…
Cardiac arrhythmias are increasing among sarcoidosis patients, and they are linked with higher hospital admission and mortality rates,…
aTyr Pharma, which developing therapies to modulate immune pathways involved in lung diseases, has announced an upcoming Phase 1b/2a…